Elon Musk's brain implant company Neuralink said on Thursday it had received Food and Drug Administration (FDA) approval to begin its first human clinical trial.
Several times since 2019, billionaire Elon Musk has predicted that his brain chip company would soon secure FDA approval for human trials. But the company's application was rejected in early 2022, and the company was working through the agency's concerns over the safety of the experimental implant.
"This is the result of incredible work by the Neuralink team in close collaboration with the FDA and is an important first step that will one day allow our technology to help many people," Neuralink said in a post. on Twitter on Thursday.
Neuralink added that the company is not yet open to a clinical trial.
Neuralink is developing a brain implant that it hopes will help paralyzed people walk again and cure other neurological diseases.